BridgeMD
New treatment option for Long COVID
Official title Long COVID Brain Fog: Cognitive Rehabilitation Trial
ClinicalTrials.gov ID: NCT06095297
What this study is testing
- What it's testing
- This study will compare two approaches to cognitive rehabilitation in adults with long COVID with persistent, mild to moderate, cognitive impairment. One approach will feature (A) web-based computer "games" that trains how quickly individuals process information that they receive through their senses; (B) in-lab training on everyday activities with important cognitive components, (C) procedures designed to transfer improvements in cognition from the treatment setting to everyday life, and (D) a non-invasive form of vagus nerve stimulation (VNS), i.e., trans-auricular VNS (taVNS).
- Time commitment: about 4 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- \>3 months post COVID
- mild or greater cognitive impairment
- moderate or greater brain fog
- impairment in performance of daily activities
- reside in community
You likely can't join if
- cognitive impairment due to developmental disability, psychiatric disorder, or substance abuse, TBI or progressive brain disease
- stroke prior to the onset of COVID
- current substance abuse disorder
- prior cognitive processing speed training on DoubleDecision or similar program
- cannot tolerate trans-auricular vagus nerve stimulation
See the full eligibility criteria
- \>3 months post COVID
- mild or greater cognitive impairment
- moderate or greater brain fog
- impairment in performance of daily activities
- reside in community
- reliable transportation to lab
- sufficiently mentally and physically fit
- adequate sight and hearing
- ability to follow directions, and retain information
- sufficient English proficiency
- cognitive impairment due to developmental disability, psychiatric disorder, or substance abuse, TBI or progressive brain disease
- stroke prior to the onset of COVID
- current substance abuse disorder
- prior cognitive processing speed training on DoubleDecision or similar program
- cannot tolerate trans-auricular vagus nerve stimulation
The study team makes the final eligibility decision.
Where it's taking place
- Birmingham, Alabama, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 4 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Birmingham, Alabama, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.